NASDAQ:ARNA
Delisted
Arena Pharmaceuticals Stock News
$99.99
+0 (+0%)
At Close: May 27, 2022
Arena Announces Corporate Update and Reports First Quarter 2020 Financial Results
08:01pm, Thursday, 07'th May 2020
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today provided a corporate update and reported financial results for the first quarter ended March 31, 2020.
The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500
12:00am, Thursday, 07'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks hitting 52-week highs May 6.)
Adverum Biotechnologies Inc...
Arena Pharmaceuticals to Present at the Bank of America Securities Healthcare Conference on May 13
12:30pm, Wednesday, 06'th May 2020
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that Preston Klassen, MD, MHS, the Company's Executive Vice President, Head of Research & Development, is scheduled to participate in a virtu
Stocks Showing Improving Market Leadership: Arena Pharmaceuticals Earns 85 RS Rating
12:00am, Tuesday, 05'th May 2020The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace
12:00am, Sunday, 03'rd May 2020
Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck...
Arena Pharmaceuticals to Release First Quarter 2020 Financial Results and Provide Corporate Update on May 7
12:30pm, Thursday, 30'th Apr 2020
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) will release its first quarter 2020 financial results and provide a corporate update on Thursday, May 7, 2020, after the close of the U.S. financial markets.
United Therapeutics (UTHR) Down Despite Q1 Earnings Beat
12:00pm, Thursday, 30'th Apr 2020
United Therapeutics (UTHR) beats estimates for both earnings and sales in first quarter. It expects a reduction in new patient starts in the future quarters. Stock down.
United Therapeutics (UTHR) Down Despite Q1 Earnings Beat
12:00pm, Thursday, 30'th Apr 2020
United Therapeutics (UTHR) beats estimates for both earnings and sales in first quarter. It expects a reduction in new patient starts in the future quarters. Stock down.
United Therapeutics (UTHR) Down Despite Q1 Earnings Beat
12:00am, Thursday, 30'th Apr 2020Arena Pharmaceuticals (NASDAQ:ARNA) Stock Price Passes Above 200-Day Moving Average of $46.90
10:00am, Tuesday, 28'th Apr 2020
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) shares crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $46.90 and traded as high as $53.00. Aren
How this Week’s Premium Top 10 Performed, April 24, 2020
08:13pm, Friday, 24'th Apr 2020
How this Week’s Premium Top 10 Performed, April 24, 2020
Posted by
Greg Harmon
on April 24th, 2020
Each week I post the performance of the stocks that were given to subscribers the previous Sunday.
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01:00pm, Friday, 24'th Apr 2020
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that on April 15, 2020, the Compensation Committee of its Board of Directors granted inducement stock options to purchase an aggregate of 39,
Are Strong Financial Prospects The Force That Is Driving The Momentum In Arena Pharmaceuticals, Inc.’s NASDAQ:ARNA) Stock?
10:27am, Friday, 24'th Apr 2020
Arena Pharmaceuticals''s (NASDAQ:ARNA) stock is up by a considerable 19% over the past month. Given the company's...
737 Shares in Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Acquired by Allworth Financial LP
08:40am, Monday, 20'th Apr 2020
Allworth Financial LP acquired a new stake in shares of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) in the first quarter, according to the company in its most recent 13F filing with the Securities & Exc
